Evidence map›Paper›PMID 40584994›Full record

ArticlePhysics and imaging in radiation oncology2025

Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapy.

Abdella M Ahmed, Levi Madden, Maegan Stewart, Brian V Y Chow, Adam Mylonas, Ryan Brown, Gabrielle Metz, Meegan Shepherd, Carlito Coronel, Leigh Ambrose and 6 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Abdella M AhmedNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Levi MaddenNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Maegan StewartNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Brian V Y ChowNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Adam MylonasACRF Image X Institute, The University of Sydney, Eveleigh, NSW 2015, Australia.
Ryan BrownNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Gabrielle MetzNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Meegan ShepherdNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Carlito CoronelNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Leigh AmbroseNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Alex TurkNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Maiko CrispinNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Andrew KneeboneNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
George HrubyNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.
Paul KeallACRF Image X Institute, The University of Sydney, Eveleigh, NSW 2015, Australia.
Jeremy T BoothNorthern Sydney Cancer Centre, Royal North Shore Hospital, Reserve Rd, St Leonards, NSW 2065, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: In pancreatic stereotactic body radiotherapy (SBRT), accurate motion management is crucial for the safe delivery of high doses per fraction. Intra-fraction tracking with magnetic resonance imaging-guidance for gated SBRT has shown potential for improved local control. Visualisation of pancreas (and surrounding organs) remains challenging in intra-fraction kilo-voltage (kV) imaging, requiring implanted fiducials. In this study, we investigate patient-specific deep-learning approaches to track the gross-tumour-volume (GTV), pancreas-head and the whole-pancreas in intra-fraction kV images. Materials and methods: Conditional-generative-adversarial-networks were trained and tested on data from 25 patients enrolled in an ethics-approved pancreatic SBRT trial for contour prediction on intra-fraction 2D kV images. Labelled digitally-reconstructed-radiographs (DRRs) were generated from contoured planning-computed-tomography (CTs) (CT-DRRs) and cone-beam-CTs (CBCT-DRRs). A population model was trained using CT-DRRs of 19 patients. Two patient-specific model types were created for six additional patients by fine-tuning the population model using CBCT-DRRs (CBCT-models) or CT-DRRs (CT-models) acquired in exhale-breath-hold. Model predictions on unseen triggered-kV images from the corresponding six patients were evaluated against projected-contours using Dice-Similarity-Coefficient (DSC), centroid-error (CE), average Hausdorff-distance (AHD), and Hausdorff-distance at 95th-percentile (HD95). Results: The mean ± 1SD (standard-deviation) DSCs were 0.86 ± 0.09 (CBCT-models) and 0.78 ± 0.12 (CT-models). For AHD and CE, the CBCT-model predicted contours within 2.0 mm ≥90.3 % of the time, while HD95 was within 5.0 mm ≥90.0 % of the time, and had a prediction time of 29.2 ± 3.7 ms per contour. Conclusion: The patient-specific CBCT-models outperformed the CT-models and predicted the three contours with 90th-percentile error ≤2.0 mm, indicating the potential for clinical real-time application.

Indexed as

CBCTDeep learningMarkerless trackingPancreas SBRT

Identifiers

PMID40584994
PMCPMC12198041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.